Vitamin D supplementation in subjects with NAFLD reduced liver fibrosis through counteracting TGF-β-induced fibrogenesis (154, 155) and reduced the inflammatory response and insulin resistance as surrogate outcomes (155, 156). This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.